Cargando…
Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology
BACKGROUND: Serum 25-hydroxyvitamin D [25(OH)D] is the major circulating form of vitamin D and a standard indicator of vitamin D status. Emerging evidence in the literature suggests a high prevalence of suboptimal vitamin D (as defined by serum 25(OH)D levels of <32 ng/ml) as well as an associati...
Autores principales: | Vashi, Pankaj G, Trukova, Kristen, Lammersfeld, Carolyn A, Braun, Donald P, Gupta, Digant |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000371/ https://www.ncbi.nlm.nih.gov/pubmed/21092237 http://dx.doi.org/10.1186/1475-2891-9-60 |
Ejemplares similares
-
The Association between Pre-Treatment Serum 25-Hydroxyvitamin D and Survival in Newly Diagnosed Stage IV Prostate Cancer
por: Gupta, Digant, et al.
Publicado: (2015) -
Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer
por: Vashi, Pankaj G, et al.
Publicado: (2011) -
Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer
por: Vashi, Pankaj, et al.
Publicado: (2016) -
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer
por: Vashi, Pankaj G., et al.
Publicado: (2015) -
Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
por: Gupta, Digant, et al.
Publicado: (2010)